Jan. 17, 2025
| Today’s news and insights for medtech leaders
|
A NOTE FROM THE EDITOR
MedTech Dive will take a publishing break on Monday, Jan. 20, for Martin Luther King Jr. Day. We will be back in your inboxes on Tuesday.
Over the long weekend, check out our look at the top medtech trends to watch in 2025.
As always, thanks for reading!
|
The new director of the FDA’s device center contrasted a European rule with the U.S.’s lack of mandatory reporting requirements for potential device shortages.
|
BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.
|
Deep Dive
How the incoming Trump administration will regulate AI this year remains unclear. Meanwhile, experts say healthcare companies will continue bolstering cyber defenses to withstand increasing attacks.
|
Tell your brand’s story. Secure prime ad placements. Generate qualified leads. Reach your marketing goals with MedTech Dive’s audience of over 206,500 decision makers.
|
CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the year ahead at the J.P. Morgan Healthcare Conference.
|
Gary Guthart gave a glimpse of surgeons’ initial response to the new robot at the J.P. Morgan Healthcare Conference.
|
UPDATED
Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.
|
|
Getting your medical device to market takes purpose-built technology and strategic planning. This guide explores clinical trial complexities, including regulatory trends, best practices and must-have tools.
|
|
From Our Library
Trendline
Supported by IQVIA
|
| 
